Pulsed Dye Laser Treatment Combined with Oral Minocycline Reduces Recurrence Rate of Rosacea
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background: The recurrence rate of rosacea was not known very well, but has been reported as 60% in 6 months after withdrawal of the drug. It is not known which treatment can reduce relapses of rosacea effectively. Objective: The objective was to identify whether 595 nm-pulsed dye laser (PDL) treatment reduced recurrence rate among rosacea patients who were treated with oral minocycline. Methods: One hundred and seven Korean patients with rosacea who started treatment with oral minocycline (100 mg/d) with or without PDL (2∼4 sessions) were evaluated retrospectively. The recurrence rate was estimated using the Kaplan-Meier method, and difference was evaluated using the log-rank test. Cox proportional hazards model was used to estimate hazard ratios and 95% confidence intervals (CIs) of risk factors for the recurrence of rosacea. Results: The recurrencefree survival analysis revealed that the group with oral minocycline plus PDL was significantly different compared with the group with oral minocycline alone (p=0.011). Cox proportional hazards model showed that the combined use of PDL with oral minocycline appeared to be a significant protective factor for the hazard of recurrence of rosacea (hazard ratio, 0.492; 95% CI, 0.257∼0.941; p=0.032). Conclusion: PDL can be used added to oral minocycline to reduce relapses among rosacea patients who are undergoing oral minocycline treatment.
Abstract
Background: The recurrence rate of rosacea was not known very well, but has been reported as 60% in 6 months after withdrawal of the drug. It is not known which treatment can reduce relapses of rosacea effectively. Objective: The objective was to identify whether 595 nm-pulsed dye laser (PDL) treatment reduced recurrence rate among rosacea patients who were treated with oral minocycline. Methods: One hundred and seven Korean patients with rosacea who started treatment with oral minocycline (100 mg/d) with or without PDL (2∼4 sessions) were evaluated retrospectively. The recurrence rate was estimated using the Kaplan-Meier method, and difference was evaluated using the log-rank test. Cox proportional hazards model was used to estimate hazard ratios and 95% confidence intervals (CIs) of risk factors for the recurrence of rosacea. Results: The recurrencefree survival analysis revealed that the group with oral minocycline plus PDL was significantly different compared with the group with oral minocycline alone (p=0.011). Cox proportional hazards model showed that the combined use of PDL with oral minocycline appeared to be a significant protective factor for the hazard of recurrence of rosacea (hazard ratio, 0.492; 95% CI, 0.257∼0.941; p=0.032). Conclusion: PDL can be used added to oral minocycline to reduce relapses among rosacea patients who are undergoing oral minocycline treatment.
참고문헌 (18)
- Two AM, "Rosacea: part I. Introduction, categorization, histology, pathogenesis, and risk factors", J Am Acad Dermatol, 72, pp.749~758 (2015)
- Korting HC, "Current topical and systemic approaches to treatment of rosacea", J Eur Acad Dermatol Venereol, 23, pp.876~882 (2009)
- Jackson JM, "Efficacy of extendedrelease 45 mg oral minocycline and extended-release 45mg oral minocycline plus 15% azelaic acid in the treatment of acne rosacea", J Drugs Dermatol, 12, pp.292~298 (2013)
- Del Rosso JQ, "Two randomized phase III clinical trials evaluating anti-inflammatory dose doxycycline (40-mg doxycycline, USP capsules) administered once daily for treatment of rosacea", J Am Acad Dermatol, 56, pp.791~802 (2007)
- Two AM, "Rosacea: part II. Topical and systemic therapies in the treatment of rosacea", J Am Acad Dermatol, 72, pp.761~770 (2015)
- Pelle MT, "Fitzpatrick's dermatology in general medicine", pp.918~924 (2012), McGraw-Hill
- Kim TG, "Enhancing effect of pretreatment with topical niacin in the treatment of rosacea-associated erythema by 585-nm pulsed dye laser in Koreans: a randomized, prospective, split-face trial", Br J Dermatol, 164, pp.573~579 (2011)
- Erceg A, "The efficacy of pulsed dye laser treatment for inflammatory skin diseases: a systematic review", J Am Acad Dermatol, 69, pp.609.e8~615.e8 (2013)
- Lonne-Rahm S, "Laser treatment of rosacea: a pathoetiological study", Arch Dermatol, 140, pp.1345~1349 (2004)
- Salem SA, "Neodymium-yttrium aluminum garnet laser versus pulsed dye laser in erythemato-telangiectatic rosacea:comparison of clinical efficacy and effect on cutaneous substance (P) expression", J Cosmet Dermatol, 12, pp.187~194 (2013)
- Aksoy B, "The impact of rosacea on quality of life: effects of demographic and clinical characteristics and various treatment modalities", Br J Dermatol, 163, pp.719~725 (2010)
- Knight AG, "A follow-up of tetracycline-treated rosacea. With special reference to rosacea keratitis", Br J Dermatol, 93, pp.577~580 (1975)
- Mikkelsen PR, "Recurrence rate and patient satisfaction of CO2 laser evaporation of lesions in patients with hidradenitis suppurativa: a retrospective study", Dermatol Surg, 41, pp.255~260 (2015)
- Roland CL, "Clinical observations and molecular variables of primary vascular leiomyosarcoma", JAMA Surg, 151, pp.347~354 (2016)
- Tan ST, "Pulsed dye laser therapy for rosacea", Br J Plast Surg, 57, pp.303~310 (2004)
- Bernstein EF, "Rosacea treatment using the new-generation, high-energy, 595 nm, long pulse-duration pulsed-dye laser", Lasers Surg Med, 40, pp.233~239 (2008)
- Togsverd-Bo K, "Short and limited effect of long-pulsed dye laser alone and in combination with photodynamic therapy for inflammatory rosacea", J Eur Acad Dermatol Venereol, 23, pp.200~201 (2009)
- Wereide K, "Long-term treatment of rosacea with oral tetracycline", Acta Derm Venereol, 49, pp.176~179 (1969)